Some of the biggest trends in pharma will also be affecting the medtech industry next year.
Tag Archive for: software
Today the FDA announced the establishment of a new Digital Health Advisory Committee to help the agency explore the complex, scientific and technical issues related to digital health technologies (DHTs), such as artificial intelligence/machine learning (AI/ML), augmented reality, virtual reality, digital therapeutics, wearables, remote patient monitoring and software.
Recursion, which has partnered with drugmakers such as Bayer and Roche, plans to use Nvidia’s software to support its own pipeline as well as current and future partners.
The COVID-19 pandemic compelled the industry to re-examine the way it conducted clinical trials, engaged with patients, and promoted to HCPs. Companies began to explore decentralized clinical trials, new non-personal promotion strategies, virtual customer engagement strategies, and new ways to engage with the patient — all with an eye toward replacing status quo processes and technologies. The result was the accelerated development of new clinical and commercial technologies and data with the ultimate goal of bringing new therapies to patients faster.
New AI technology holds the key to improving knowledge exchange and implementation in real-world clinical practice.
Part III: Leaders in healthcare marketing and communications explain where technology will have the most impact on the industry.
On the heels of the upcoming major digital therapeutics show in Boston (DTx East), EVERSANA has announced a partnership with Warsaw, Poland-based Prosoma Digital Therapeutics. Together, they will work together to bring the company’s Living Well digital therapy to the U.S. to improve the quality of life and reduce stress, anxiety, and depression symptoms for patients related to a cancer diagnosis.
Over the past decade, the clinical research industry has steadily adopted new digital technologies to streamline business processes and improve user experiences, realizing efficiencies and insights along the way.
ANI Pharmaceuticals shares how a data-driven go-to-market approach can help lean teams effectively launch and grow rare diseases brands.
Providers continue to adapt to the new care models to patients’ needs. As the pandemic wreaked havoc across the United States, healthcare providers started deploying various health IT solutions to address emerging challenges. They aimed to reduce the load on doctors and protect clinicians and patients from the virus exposure.
